Suppr超能文献

急性心力衰竭早期利尿剂和硝酸盐联合使用与30天预后的关系:ELISABETH研究的辅助分析

Association of early doses of diuretics and nitrates in acute heart failure with 30 days outcomes: ancillary analysis of ELISABETH study.

作者信息

Gorlicki Judith, Nekrouf Célia, Miró Òscar, Cotter Gad, Davison Beth, Mebazaa Alexandre, Simon Tabassome, Freund Yonathan

机构信息

Inserm UMR-S 942, MASCOT, Paris.

Emergency Department, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Sorbonne Paris Nord, Bobigny.

出版信息

Eur J Emerg Med. 2025 Feb 1;32(1):46-51. doi: 10.1097/MEJ.0000000000001165. Epub 2024 Jul 31.

Abstract

AIMS

The optimal dose of diuretics and nitrates for acute heart failure treatment remains uncertain. This study aimed to assess the association between intravenous nitrates and loop diuretics doses within the initial 4 h of emergency department presentation and the number of days alive and out of hospital (NDAOH) through 30 days.

METHODS

This was an ancillary study of the ELISABETH stepped-wedge cluster randomized trial that included 502 acute heart failure patients 75 years or older in 15 French emergency departments. The primary endpoint was the NDAOH at 30 days. The total dose of intravenous nitrates and loop diuretics administered in the initial 4 h were each categorized into three classes: 'no nitrate', '> 0-16', and '> 16 mg' for nitrates and '< 60', '60', and '> 60 mg' for diuretics. Secondary endpoints included 30-day mortality, 30-day hospital readmission, and hospital length of stay in patients alive at 30 days. Generalized linear mixed models were used to examine associations with the endpoints.

RESULTS

Of 502 patients, the median age was 87 years, with 59% women. The median administered dose within the initial 4 h was 16 mg (5.0; 40.0) for nitrates and 40 mg (40.0; 80.0) for diuretics. The median NDAOH at 30 days was 19 (0.0-24.0). The adjusted ratios of the NDAOH were 0.88 [95% confidence interval (CI): 0.63-1.23] and 0.76 (95% CI: 0.58-1.00) for patients that received 60 and > 60 mg, respectively, compared with patients that received 40 mg or less of diuretics. Compared with patients who did not receive nitrates, the adjusted ratios of the NDAOH were 1.17 (95% CI: 0.82-1.67) and 1.45 (95% CI: 0.90-2.33) for patients who received 1-16 and > 16 mg, respectively. There was no significant association with any of the secondary endpoints.

CONCLUSION

In this ancillary analysis, there was no significant association between different doses of diuretics and nitrates with the NDAOH at 30 days. Point estimates and CIs may suggest that the optimal doses are less than 60 mg of diuretics, and more than 16 mg of nitrates in the first 4 h.

摘要

目的

用于急性心力衰竭治疗的利尿剂和硝酸盐的最佳剂量仍不确定。本研究旨在评估急诊科就诊最初4小时内静脉注射硝酸盐和袢利尿剂的剂量与30天内存活且未住院天数(NDAOH)之间的关联。

方法

这是ELISABETH阶梯楔形整群随机试验的一项辅助研究,纳入了法国15个急诊科的502例75岁及以上的急性心力衰竭患者。主要终点是30天的NDAOH。最初4小时内静脉注射硝酸盐和袢利尿剂的总剂量分别分为三类:硝酸盐为“无硝酸盐”、“>0 - 16”和“>16毫克”,利尿剂为“<60”、“60”和“>60毫克”。次要终点包括30天死亡率、30天再入院率以及30天存活患者的住院时长。使用广义线性混合模型来检验与终点的关联。

结果

502例患者中,中位年龄为87岁,女性占59%。最初4小时内硝酸盐的中位给药剂量为16毫克(5.0;40.0),利尿剂为40毫克(40.0;80.0)。30天的NDAOH中位数为19(0.0 - 24.0)。与接受40毫克或更少利尿剂的患者相比,接受60毫克和>60毫克利尿剂的患者NDAOH的调整比值分别为0.88 [95%置信区间(CI):0.63 - 1.23]和0.76(95% CI:0.58 - 1.00)。与未接受硝酸盐的患者相比,接受1 - 16毫克和>16毫克硝酸盐的患者NDAOH的调整比值分别为1.17(95% CI:0.82 - 1.67)和1.45(95% CI:0.90 - 2.33)。与任何次要终点均无显著关联。

结论

在这项辅助分析中,不同剂量的利尿剂和硝酸盐与30天的NDAOH之间无显著关联。点估计值和置信区间可能表明,最佳剂量为最初4小时内利尿剂少于60毫克,硝酸盐多于16毫克。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验